Associations between metabolic syndrome and gynecologic cancer
Da Yong Lee, Taek Sang Lee
Obstet Gynecol Sci. 2020;63(3):215-224.   Published online 2020 Mar 31     DOI:
Citations to this article as recorded by Crossref logo
Statins as adjuvants in the treatment of ovarian cancer: Controversy and misunderstanding
Natalia Manzano-León, Patricia Garcia-Lopez
European Journal of Pharmacology.2021; 896: 173915.     CrossRef
ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease
Laris Achlaug, Lina Somri-Gannam, Shilhav Meisel-Sharon, Rive Sarfstein, Manisha Dixit, Shoshana Yakar, Mordechai Hallak, Zvi Laron, Haim Werner, Ilan Bruchim
Frontiers in Endocrinology.2021;[Epub]     CrossRef
Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers
Antonio J. León-González, Juan M. Jiménez-Vacas, Antonio C. Fuentes-Fayos, Andre Sarmento-Cabral, Aura D. Herrera-Martínez, Manuel D. Gahete, Raúl M. Luque
Current Opinion in Pharmacology.2021; 60: 17.     CrossRef
The Accuracy of Visceral Adiposity Index for the Screening of Metabolic Syndrome: A Systematic Review and Meta-Analysis
Moniba Bijari, Sara Jangjoo, Nima Emami, Sara Raji, Mahdi Mottaghi, Roya Moallem, Ali Jangjoo, Amin Saberi, Pawel Grzmil
International Journal of Endocrinology.2021; 2021: 1.     CrossRef
The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
Hyeong In Ha, Ha Kyun Chang, Soo Jin Park, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
Obstetrics & Gynecology Science.2021; 64(5): 444.     CrossRef
Obesity and gynecological cancers: A toxic relationship
Ignacio A. Wichmann, Mauricio A. Cuello
International Journal of Gynecology & Obstetrics.2021; 155(S1): 123.     CrossRef